MAA
EGRX

Managed Account Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Managed Account Advisors’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$32K Buy
+392
New +$25.5K ﹤0.01% 2722

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Managed Account Advisors's EGRX Position: Q2 2015 in Review

Managed Account Advisors opened a new position in Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2015: 392 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #2722 among its holdings.

120 funds tracked by Wall St. Rank hold EGRX as of Q2 2015.

  • Managed Account Advisors held 392 shares of Eagle Pharmaceuticals, Inc. worth $32K as of Q2 2015.
  • Eagle Pharmaceuticals, Inc. was a new Managed Account Advisors position in Q2 2015.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2722 holding.
  • 120 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.